Covishield Vaccination Side Effects and Warning signs to not ignore
According to a story by The Telegraph, the UK pharmaceutical giant AstraZeneca has recognized that there is a chance that the COVID-19 vaccination might result in Thrombosis with Thrombocytopenia Syndrome, an uncommon adverse effect.
During the pandemic, AstraZeneca worked with Oxford University to create the vaccine, which was produced by the Serum Institute of India and used in India under the name Covishield.
Thrombosis with Thrombocytopenia Syndrome (TTS): What is it?
A uncommon but dangerous disorder known as thrombosis with thrombocytopenia syndrome (TTS) has been associated with several COVID-19 vaccinations, most notably the adenovirus vector vaccines such as AstraZeneca and Johnson & Johnson’s Janssen vaccine.
Symptoms
Severe or ongoing headaches, impaired vision, dyspnea, chest discomfort, leg swelling, ongoing abdomen pain, and easy bruising or small blood spots beneath the skin beyond the injection site are some of the symptoms that may be experienced.
Even though TTS is uncommon, those who have had vaccinations linked to it should watch out for symptoms and get help right once if they appear within a few weeks after the shot. Effective management of TTS requires early detection and intervention.